Logo image of MTRX

MATRIX SERVICE CO (MTRX) Stock Fundamental Analysis

NASDAQ:MTRX - Nasdaq - US5768531056 - Common Stock - Currency: USD

14.59  +0.08 (+0.55%)

After market: 14.59 0 (0%)

Fundamental Rating

3

MTRX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. The financial health of MTRX is average, but there are quite some concerns on its profitability. MTRX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MTRX had negative earnings in the past year.
MTRX had a positive operating cash flow in the past year.
MTRX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTRX reported negative operating cash flow in multiple years.
MTRX Yearly Net Income VS EBIT VS OCF VS FCFMTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

MTRX has a Return On Assets of -3.68%. This is in the lower half of the industry: MTRX underperforms 73.47% of its industry peers.
With a Return On Equity value of -14.97%, MTRX is not doing good in the industry: 73.47% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.68%
ROE -14.97%
ROIC N/A
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
MTRX Yearly ROA, ROE, ROICMTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MTRX's Gross Margin of 5.93% is on the low side compared to the rest of the industry. MTRX is outperformed by 77.55% of its industry peers.
In the last couple of years the Gross Margin of MTRX has declined.
The Profit Margin and Operating Margin are not available for MTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
MTRX Yearly Profit, Operating, Gross MarginsMTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

4

2. Health

2.1 Basic Checks

MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTRX has more shares outstanding
MTRX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MTRX Yearly Shares OutstandingMTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTRX Yearly Total Debt VS Total AssetsMTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MTRX has an Altman-Z score of 1.63. This is a bad value and indicates that MTRX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.63, MTRX is not doing good in the industry: 63.27% of the companies in the same industry are doing better.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.63
ROIC/WACCN/A
WACC11.24%
MTRX Yearly LT Debt VS Equity VS FCFMTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MTRX has a Current Ratio of 1.00. This is a normal value and indicates that MTRX is financially healthy and should not expect problems in meeting its short term obligations.
MTRX's Current ratio of 1.00 is on the low side compared to the rest of the industry. MTRX is outperformed by 73.47% of its industry peers.
MTRX has a Quick Ratio of 1.00. This is a bad value and indicates that MTRX is not financially healthy enough and could expect problems in meeting its short term obligations.
MTRX has a Quick ratio of 0.99. This is in the lower half of the industry: MTRX underperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.99
MTRX Yearly Current Assets VS Current LiabilitesMTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

MTRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.30%, which is quite impressive.
The Revenue has decreased by -0.30% in the past year.
MTRX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.46% yearly.
EPS 1Y (TTM)23.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%20.57%

3.2 Future

Based on estimates for the next years, MTRX will show a very strong growth in Earnings Per Share. The EPS will grow by 44.31% on average per year.
The Revenue is expected to grow by 11.09% on average over the next years. This is quite good.
EPS Next Y38.42%
EPS Next 2Y61.29%
EPS Next 3Y44.31%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y12.92%
Revenue Next 3Y11.09%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MTRX Yearly Revenue VS EstimatesMTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
MTRX Yearly EPS VS EstimatesMTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 22.89, MTRX is valued on the expensive side.
MTRX's Price/Forward Earnings ratio is in line with the industry average.
MTRX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.94.
Industry RankSector Rank
PE N/A
Fwd PE 22.89
MTRX Price Earnings VS Forward Price EarningsMTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

MTRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MTRX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.44
EV/EBITDA N/A
MTRX Per share dataMTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTRX's earnings are expected to grow with 44.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.29%
EPS Next 3Y44.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MATRIX SERVICE CO

NASDAQ:MTRX (8/20/2025, 8:12:24 PM)

After market: 14.59 0 (0%)

14.59

+0.08 (+0.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners87.86%
Inst Owner Change1.16%
Ins Owners4%
Ins Owner Change0%
Market Cap402.83M
Analysts82.86
Price Target17.34 (18.85%)
Short Float %2.47%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.15%
Min EPS beat(2)-132.96%
Max EPS beat(2)12.66%
EPS beat(4)2
Avg EPS beat(4)-21.77%
Min EPS beat(4)-132.96%
Max EPS beat(4)34.64%
EPS beat(8)3
Avg EPS beat(8)-68.85%
EPS beat(12)4
Avg EPS beat(12)-89.55%
EPS beat(16)4
Avg EPS beat(16)-181.58%
Revenue beat(2)0
Avg Revenue beat(2)-4.82%
Min Revenue beat(2)-8.75%
Max Revenue beat(2)-0.89%
Revenue beat(4)0
Avg Revenue beat(4)-5.57%
Min Revenue beat(4)-8.75%
Max Revenue beat(4)-0.89%
Revenue beat(8)0
Avg Revenue beat(8)-7.24%
Revenue beat(12)2
Avg Revenue beat(12)-5.13%
Revenue beat(16)3
Avg Revenue beat(16)-4.79%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-95.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-144.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.89
P/S 0.54
P/FCF 3.44
P/OCF 3.25
P/B 2.67
P/tB 3.33
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)0.64
Fwd EY4.37%
FCF(TTM)4.24
FCFY29.05%
OCF(TTM)4.48
OCFY30.72%
SpS26.89
BVpS5.46
TBVpS4.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.68%
ROE -14.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM 15.76%
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 65.83%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.99
Altman-Z 1.63
F-Score6
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)50.41%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
EPS Next Y38.42%
EPS Next 2Y61.29%
EPS Next 3Y44.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%20.57%
Revenue Next Year5.89%
Revenue Next 2Y12.92%
Revenue Next 3Y11.09%
Revenue Next 5YN/A
EBIT growth 1Y0.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.4%
EBIT Next 3Y54%
EBIT Next 5YN/A
FCF growth 1Y412.1%
FCF growth 3YN/A
FCF growth 5Y24.61%
OCF growth 1Y522.7%
OCF growth 3YN/A
OCF growth 5Y11.89%